The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab versus nivolumab with ipilimumab versus trifluridine/tipiracil for metastatic microsatellite instability-high colorectal cancer: A modeling decision analysis.
 
Jacqueline N. Chu
No Relationships to Disclose
 
Jin G. Choi
No Relationships to Disclose
 
Sassan Ostvar
No Relationships to Disclose
 
James A. Torchia
No Relationships to Disclose
 
Kerry Lynn Reynolds
No Relationships to Disclose
 
Justin F. Gainor
Honoraria - ARIAD; Incyte; Merck
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Genentech; Loxo; Novartis; Theravance
Research Funding - Adaptimmune; ARIAD; AstraZeneca; Bristol-Myers Squibb; Genentech; Merck; Novartis
Travel, Accommodations, Expenses - Affymetrix
 
Daniel C. Chung
No Relationships to Disclose
 
Jeffrey W. Clark
No Relationships to Disclose
 
Chin Hur
No Relationships to Disclose